The utilization of GLUT5-specific radiotracers within positron emission tomography (PET) and single-photon emission computed tomography (SPECT) enhances molecular imaging of BC cells with improved deep-tissue penetrability and potential for clinical use. The gene discussed is SLC2A5; the disease is breast cancer.